Cargando…
Reversible changes in pancreatic islet structure and function produced by elevated blood glucose
Diabetes is characterized by hyperglycaemia due to impaired insulin secretion and aberrant glucagon secretion resulting from changes in pancreatic islet cell function and/or mass. The extent to which hyperglycaemia per se underlies these alterations remains poorly understood. Here we show that β-cel...
Autores principales: | Brereton, Melissa F., Iberl, Michaela, Shimomura, Kenju, Zhang, Quan, Adriaenssens, Alice E., Proks, Peter, Spiliotis, Ioannis I., Dace, William, Mattis, Katia K., Ramracheya, Reshma, Gribble, Fiona M., Reimann, Frank, Clark, Anne, Rorsman, Patrik, Ashcroft, Frances M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Pub. Group
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4143961/ https://www.ncbi.nlm.nih.gov/pubmed/25145789 http://dx.doi.org/10.1038/ncomms5639 |
Ejemplares similares
-
Na(+) current properties in islet α- and β-cells reflect cell-specific Scn3a and Scn9a expression
por: Zhang, Quan, et al.
Publicado: (2014) -
Hyperglycaemia induces metabolic dysfunction and glycogen accumulation in pancreatic β-cells
por: Brereton, Melissa F., et al.
Publicado: (2016) -
A Mouse Model of Human Hyperinsulinism Produced by the E1506K Mutation in the Sulphonylurea Receptor SUR1
por: Shimomura, Kenju, et al.
Publicado: (2013) -
Insulin inhibits glucagon release by SGLT2-induced stimulation of somatostatin secretion
por: Vergari, Elisa, et al.
Publicado: (2019) -
Glucose stimulates somatostatin secretion in pancreatic δ-cells by cAMP-dependent intracellular Ca(2+) release
por: Denwood, Geoffrey, et al.
Publicado: (2019)